Latest filing published 02 Apr 2026 for 서린바이오.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -28.2%Entry ₩6,100 · Close at T+90 ₩4,378
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
안광기: trading record in brief
All filings by 안광기 on record concern 서린바이오. The record holds 2 filings, for trades running from 18 March 2022 to 26 March 2026.
No open-market sale appears; the market trades are 2 purchases. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 1 purchase and no sales on the market.
The record was last updated on 2 April 2026 with an open-market purchase in 서린바이오. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 안광기
Open company profiles for insider transactions, fundamentals and analyst consensus when available.